View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Infectious Diseases News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 09, 2024
2 min read
Save

Mediterranean diet may provide long-term strategy to reduce COVID-19 risk

Mediterranean diet may provide long-term strategy to reduce COVID-19 risk

Greater compliance with components of the Mediterranean diet significantly reduced the risk for developing of COVID-19, according to the findings of a recent analysis.

SPONSORED CONTENT
September 09, 2024
3 min read
Save

Study identifies ways to improve antiviral prescribing for infants with flu

Study identifies ways to improve antiviral prescribing for infants with flu

Presence of a fever and time since symptom onset were two factors that affected whether providers prescribed oseltamivir to infants with influenza, according to findings published in Journal of the Pediatric Infectious Diseases Society.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
September 06, 2024
2 min read
Save

Study: Highlighting harms of not being vaccinated could overcome hesitancy

Study: Highlighting harms of not being vaccinated could overcome hesitancy

Clinicians could help patients overcome vaccine hesitancy by highlighting the potential harms of not being vaccinated rather than emphasizing the benefits of a vaccine, according to a study published in the Journal of Public Health.

SPONSORED CONTENT
September 06, 2024
2 min read
Save

WHO: Global cholera deaths increased by 71%

WHO: Global cholera deaths increased by 71%

WHO this week announced that cholera cases increased by 13% and cholera deaths increased by 71% globally in 2023.

SPONSORED CONTENT
September 05, 2024
3 min read
Save

Q&A: RSV vaccination lowers risk for hospitalization in older patients

Q&A: RSV vaccination lowers risk for hospitalization in older patients

During their first season in use, respiratory syncytial virus vaccines reduced the risk for RSV-associated hospitalization by 75% among adults aged 60 years or older, according to a study.

SPONSORED CONTENT
September 05, 2024
5 min read
Save

Q&A: What physicians should know about the COVID-19 summer surge and updated vaccines

Q&A: What physicians should know about the COVID-19 summer surge and updated vaccines

Considering the current surge of COVID-19 cases, primary care providers should counsel patients to prepare for this winter’s inevitable spike, according to an expert.

SPONSORED CONTENT
September 05, 2024
2 min read
Save

Risk for myalgic encephalomyelitis/chronic fatigue syndrome no greater after COVID-19

Risk for myalgic encephalomyelitis/chronic fatigue syndrome no greater after COVID-19

COVID-19 does not increase patients’ risk for developing myalgic encephalomyelitis/chronic fatigue syndrome during the 1-year period post infection, according to a registry study published in JAMA Network Open.

SPONSORED CONTENT
September 04, 2024
2 min read
Save

Nasal S. aureus colonization accounts for most postoperative staph infections

Nasal <i>S</i><i>.</i><i> aureus</i> colonization accounts for most postoperative staph infections

Nasal colonization with Staphylococcus aureus accounted for most postoperative staph infections in a large cohort of adults who underwent surgery, according to a study published in Open Forum Infectious Diseases.

SPONSORED CONTENT
September 04, 2024
2 min read
Save

Incidence of invasive aspergillosis varies among children with leukemia

Incidence of invasive aspergillosis varies among children with leukemia

Invasive aspergillosis occurs in around 3% to 5% of children with acute leukemia, according to findings published in Journal of the Pediatric Infectious Diseases Society.

SPONSORED CONTENT
September 03, 2024
1 min read
Save

COVID-19 vaccine pipeline could bring more changes to ‘menu of options’

COVID-19 vaccine pipeline could bring more changes to &lsquo;menu of options&rsquo;

Given the nuances of COVID-19 vaccine protection, Kizzmekia Corbett-Helaire, PhD, an assistant professor of immunology and infectious diseases at Harvard's School of Public Health, said the U.S. “should remain diligent in reviewing efficacy and safety data of each COVID-19 vaccine update to make progressional recommendations.”

View more